CIK 0001139685 · <br>Emerging growth company
20/20 Biolabs, Inc.
Sign in to watch- Ticker
- AIDX
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522272107
- Phone
- 2404536339
- Business address
- 9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD, 20850
- Former names
- 20/20 GeneSystems, Inc., 20/20 GENE SYSTEMS INC
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- NT 10-Q Other NT 10-Q
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-1 Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 2 of 9 · 167 filings